Background Much progress has been made in interventions to prevent HIV infection. However, development of evidence-informed prevention programmes that translate the effi cacy of these strategies into population eff ect remain a challenge. In this systematic review, we map current evidence for HIV prevention against a new classifi cation system, the HIV prevention cascade.
Introduction
Despite progress in development and delivery of effi cacious HIV prevention interventions, more than 1 million people are newly infected with HIV every year. 1 UNAIDS have called for a reinvigoration of HIV prevention methods and suggest that 25% of global HIV spending should be allocated to prevention activities. 2 There is growing interest in the use of HIV prevention cascades to support the development and implementation of interventions and to facilitate resource allocation. In this issue, Hargreaves and colleagues 3 suggest a reframing of HIV prevention interventions organised around an HIV prevention cascade that can both integrate evidence from diff erent disciplines and be more helpful for programmers. Garnett and colleagues 4 use observational data from Zimbabwe to operationalise the idea of an HIV prevention cascade as a monitoring tool. In this paper, we review the available evidence for HIV prevention as refl ected in systematic reviews of HIV prevention interventions published during the past 20 years. We map the evidence base in line with the HIV prevention cascade, describe characteristics of interventions relevant to each area of the cascade, assess the type of evidence available on these interventions, and identify gaps and areas for future research.
Methods

Search strategy and selection of reviews
We did three independent systematic searches to identify systematic reviews of HIV prevention interventions published in English from Jan 1, 1995. Search terms included HIV/AIDS MeSH terms, "behav*" (behavioural review), "struct*" (structural review), "prevent*" and "intervention", and terms specifi c to each included biomedical intervention.
To identify systematic reviews of biomedical HIV prevention interventions, on Aug 15, 2014, we searched the Cochrane Library, MEDLINE, ISI Web of Knowledge, and ClinicalTrials.gov. The search fi ndings were updated on July 20, 2015, when we extended the search to include Embase and no longer limited it to systematic reviews so that we could identify primary studies from 2012 that might not have been incorporated into reviews. To identify systematic reviews of behavioural interventions, on May 12-15, 2015, we searched the Cochrane Library, Embase, Health-Evidence.org, MEDLINE, and PsycNET and for papers that described interventions implemented. To identify systematic reviews of structural interventions, we searched the Cochrane Library, MEDLINE, ISI Web of Knowledge, and Health-Evidence.org. We did the initial search for reviews about structural interventions on Aug 1-10, 2014, and updated the results on May 15, 2015. Data were extracted from reviews with a data extraction tool (appendix 1) Reviews were eligible for inclusion if they systematically reviewed the evidence on the eff ectiveness of HIV prevention interventions. Reviews of experimental and observational studies were included. There were no restrictions on populations. We excluded broad overviews, scoping reviews, and unsystematic literature reviews.
We excluded reviews containing studies of behavioural interventions and structural interventions done only in high-income countries because we wanted to focus on areas in which HIV burden is highest and because the eff ectiveness of such interventions could be context specifi c and the heterogeneity of studies would present even greater challenges to data synthesis. We did not exclude any countries of implementation for reviews about the effi cacy of biomedical products, because effi cacy trials are not as heavily aff ected by contextual factors and so we considered the country-focus restriction less pertinent.
Primary study identifi cation and data extraction
We extracted primary studies from reviews if they assessed at least one of the following outcomes: HIV incidence, HIV prevalence, reported condom use, and uptake of HIV testing. For studies of direct mechanisms only, HIV incidence had to be a primary outcome to qualify for inclusion. We included condom use and uptake of HIV testing as proximate outcomes of intervention eff ectiveness because these are two of the most commonly reported outcomes in studies that do not report biological HIV outcomes. Although prevention of mother-to-child-transmission interventions and outcomes were identifi ed by some reviews, here we aimed to look specifi cally at sexual transmission or transmission through needle sharing.
We developed an approach for minimal data extraction at the primary study level (appendix 2); data included the country of focus, target population, study design, reported outcomes, and overall fi ndings of each study. We classifi ed reviews and primary studies with the HIV prevention cascade typology described by Hargreaves and colleagues. 3 Many primary studies fi t into more than one category, but we allocated each study into one category only based on what we judged the most prominent component seemed to be, despite recognising that some interventions include components targeting more than one of three domains: demand-side, supplyside, and adherence (table 1) .
The demand-side domain contained studies in which we judged the main aim of intervention to be to infl uence behaviour by targeting risk perception or strengthening awareness of, and positive attitudes towards, HIV prevention behaviours and technologies. These interventions include those providing information, education, and communication and those intended to infl uence perceived norms through peer-based approaches. Interventions were delivered in a range of settings and to diff erent target populations.
The supply-side domain contained studies in which we judged the main aim of intervention to be to infl uence
Research in context
Evidence before this study We did a systematic review of reviews for domains across the HIV prevention cascade. Because we restricted our search to review articles, we are confi dent that we would have identifi ed any additional reviews of reviews on a similar scale to this work. Our search identifi ed several overviews of the literature on HIV prevention, but few systematic reviews of reviews. One review published in 2013 searched for and described evidence for HIV prevention interventions as they pertain specifi cally to young people and adolescents. We refer to the methods used in this review in our work, and we have based the appraisal and rating of the evidence in our review on that previous review.
Added value of this study
To our knowledge, this is the fi rst review of reviews on HIV prevention of this size and scope. We map the evidence across the HIV prevention cascade and show strong evidence for the effi cacy of biomedical tools such as of pre-exposure prophylaxis (PrEP) and voluntary medical male circumcision and for increasing supply of biomedical tools such as condoms or clean needles. By mapping the published work in this way, we present evidence in a format that we hope will be useful to programme developers and implementers and that will provide an evidence base to inform policy on HIV prevention.
Implications of all the available evidence
We highlight the importance of combination HIV prevention interventions that address structural and behavioural barriers to the uptake, use of, and adherence to strategies known to prevent HIV. Future research for biomedical tools with demonstrated effi cacy should focus on population-level eff ectiveness. Research on increasing supply of these tools should use more rigorous study designs to measure impact in specifi c populations, including cluster randomised trials where feasible; if not feasible, a range of alternative impact designs are available. Although a range of interventions seek to address demand for HIV prevention, these have rarely been studied using experimental trials, and, where studied, have shown heterogeneous eff ectiveness. Similarly, studies of interventions to support use or adherence to HIV prevention need further adaptation and study aligned with the new HIV prevention cascade.
the supply of HIV prevention products and messages. Examples included mass condom distribution, needle exchange initiatives mainstreaming HIV prevention within other services, and treatment strategies for sexually transmitted infections (STIs). Some, but not all, of these interventions have been characterised as structural interventions in published work.
The adherence domain contained studies in which we judged the main aim of intervention to be to support adoption or maintenance of prevention behaviours, including, but not restricted to, the use of prevention technologies. These interventions often sought to infl uence behavioural self-effi cacy or skills and included interventions such as longitudinal risk counselling. We also included within this group interventions that targeted social determinants of behaviour hypothesised to act as barriers to the ability of individuals to access or adhere to prevention, such as cash transfers or livelihood interventions. Again, some of these interventions have been identifi ed as structural in the published work.
Studies in the direct mechanism domain were most often individually randomised trials of the effi cacy of biomedical products or procedures (eg, pre-exposure prophylaxis [PrEP] or medical male circumcision).
Within each of these domains, we identifi ed specifi c types of interventions. In describing each intervention type, we categorised the evidence according to the target population (table 1). We assessed the type and direction of the evidence for each of the four outcomes based on study design and reported fi ndings (appendix 2). We used a framework created by Mavedzenge and colleagues 5 in their review of the evidence for interventions for young people and adolescents. We fi rst described the study designs in each category with use of the ratings A, B, or C on the basis of how many randomised controlled trials were published for a specifi c outcome (table 2). We then assessed how many studies had fi ndings that suggested intervention eff ectiveness or not, assigning a score of 1-4 (table 2). Two reviewers (SK and BH) assessed the evidence for structural and behavioural interventions. Disagreements, although rare, were resolved after consultation and detailed review of the studies in question. One reviewer (JE) assessed the evidence for biomedical interventions.
Role of the funding source
The funder of the study had no role in data collection, data analysis, data interpretation, or writing of the report; however, the decision to focus only on evidence from low-income and middle-income countries for the behavioural and structural reviews was made, in part, by the funder. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Findings
We identifi ed 88 eligible reviews (fi gure 1A), 6-93 from which we extracted 292 primary studies (fi gure 1B). Of 194 primary studies of demand-side, supply-side, or adherence inter ventions, 137 (71%) used observational study designs (fi gure 2). 34 (38%) of 90 randomised controlled trials (RCTs) were trials of direct mechanisms to prevent HIV. 24 (12%) of the studies classifi ed as demand-side, supply-side, or adherence included HIV incidence or prevalence or both as primary outcomes, whereas almost all (88%) reported condom use. 54 primary studies from 40 reviews contributed evidence for information, education, and communication interventions (table 3) . The interventions included many diff erent approaches to infl uence risk perception, awareness, and attitudes about preventive behaviours, including through multimedia, text messages, posters, and other forms of communication. For example, the Helping Each Other Act Responsibly Together (HEART) campaign in Zambia included a multimedia programme of television spots, public service announcements, radio advertisements, music videos, posters, and billboards to share messages about HIV and STI risk reduction. 94 A secondary-school-based programme in KwaZulu-Natal provided sexual health and HIV prevention messages through either drama performances or an information 95 Slightly more than half (56%; n=30) of the information, education, and communication studies were of interventions focused on young people. An example is the MEMA Kwa Vijana cluster RCT of an intervention that provided primary school students with sexual health education through a participatory, teacher-led programme combined with training for health workers to provide sexual health services that are friendly to young people, as well as condom promotion and provision and community mobilisation. 96 Almost all studies of information, education, and communication interventions assessed condom use as a primary outcome (table 3) . 31 reviews contributed 54 studies of peer-based interventions (table 3) . Interventions in this category often combined peer-delivered sexual health education with either increased availability of direct mechanisms to prevent HIV, such as condoms, or community empowerment approaches. Studies of interventions targeted at female sex workers used peer-led community empowerment approaches to support mobilising female sex workers and developing a sense of community. An example is a peer-delivered education programme among establishment-based female sex workers in the Philippines, which combined venue-manager training with information on HIV and condom use. 97, 98 Studies assessing the impact of these interventions on HIV incidence and prevalence among female sex workers used experimental and observational designs, but they showed little evidence to support their eff ectiveness on reducing HIV incidence or prevalence (table 3) . 12 studies described peer-based interventions among young people. Examples include a project in Kenya that involved peer educators teaching students about HIV and life skills with songs, quizzes, competitions, and other methods; and Stepping Stones, an intensive community training programme designed for HIV-vulnerable communities in low-income countries. The participatory learning approach sought to empower men and women to take greater control over their sexual and emotional relationships. 99, 100 12 reviews contributed 35 studies on supply-side interventions (table 3) . Approaches were often facilitated by policy changes, such as to increase access to free clean needles or subsidised condoms for populations most at risk (table 3) . In Thailand, the 100% condom-use policy launched in 1989 promoted the practice of ''no condomno sex'' in all types of sex work through collaborations between local authorities, sex business owners, and sex workers. 101 Similar approaches have been implemented in the Dominican Republic and Cameroon, 102, 103 and adaptations for other population groups such as young people have also been attempted. Among the 20 primary studies describing the eff ectiveness of condom distribution interventions, three measured HIV prevalence, and all used observational study designs. Among six obser vational primary studies of exchange programmes for clean needles and syringes, three assessed HIV incidence as an outcome. Findings from one study supported eff ectiveness, whereas two did not (C3 ; table 3) . Two observational studies measured HIV incidence and demonstrated fi ndings in support of the intervention (C1). Three studies (all RCTs) described interventions aimed at STI control. These interventions aimed to increase access to STI testing and treatment. For example, in Rakai, Uganda, an intensive STI control programme via home-based mass antibiotic treatment was rolled out and studied in a cluster RCT design. 104 16 reviews provided 51 studies of interventions to support the adoption and maintenance of prevention behaviours by infl uencing effi cacy and skills through counselling-based interventions or interventions targeting socioeconomic determinants. 26 primary studies described use of counselling alone or with HIV testing to promote HIV prevention. Seven reviews contributed evidence from studies describing couples-based counselling inter ventions (n=10). One observational study assessed the eff ect of couples-based counselling on HIV incidence with fi ndings in support of the intervention (C1; 105 Seven studies (four RCTs) assessed HIV-positive prevention counselling. For example, an RCT in South Africa studied an intervention that consisted of patient-centred discussions between counsellors and patients living with HIV during regular clinical visits focused on HIV risk reduction and tailored to specifi c patient needs. 106 Interventions to address socioeconomic barriers to adherence to HIV prevention behaviours or other direct prevention mechanisms were based either on incentives or cash payments or on strengthening livelihoods through microfi nance or related initiatives. Cash transfer interventions aimed to improve school attendance and educational outcomes and through this mechanism reduce HIV infection rates among young people. 107 Other interventions used a contingency management model, such as that in smoking cessation programmes, in which regular behaviour monitoring was combined with fi nancial incentives when the desired behaviour was demonstrated. 108 Livelihood interventions involved training of participants in the development of products or services, access to markets, fi nancial skills, and fi nancial support or credit. The interventions sought to strengthen livelihoods among participants to alleviate poverty and increase self-effi cacy. Microfi nance interventions included the provision of small loans, assistance with the facilitation of income-generating activities, or provision of fi nancial services. 61 In some cases, interventions were combined with life-skills interventions and condom distribution including in studies from Kenya and Zimbabwe. 109, 110 29 systematic reviews (in 28 publications) in corporated 98 primary studies of six direct mechanisms to prevent HIV (table 3) . 38 studies, including three large RCTs, assessed the impact of medical male circumcision on HIV acquisition in heterosexual men (A1; table 3). 66 Cohort studies pre-dating the trials also indicated a protective eff ect for heterosexual men, including those at high risk. 67 A systematic review and meta-analysis covering seven primary studies, including one RCT, did not provide evidence of a protective eff ect of male circumcision for women (B3). 75 Four reviews provided 19 primary studies exploring whether circumcision protects men who have sex with men (MSM). No RCTs were found, but two subanalyses of observational data by partner role suggest, to varying extents, that circumcision might give a protective eff ect for MSM with a predominantly or exclusive insertive role. 76, 77 Two reviews describe evidence from six RCTs done between 2007 and 2009 to assess the eff ect on HIV incidence of oral PrEP (of daily tenofovir disoproxil fumarate, with or without emtricitabine, vs placebo). [82] [83] [84] Four trials showed fi ndings in support of the intervention, with an effi cacy of up to 75%, whereas two, which included women only, did not show any eff ect (as was also the case in the more recent VOICE trial. One RCT assessed the effi cacy of PrEP on HIV incidence among people who inject drugs (B1) and one assessed the effi cacy of PrEP on HIV incidence among MSM (B1). This latter RCT, the iPrEx trial, was done in six countries and involved approximately 2500 men comparing daily tenofovir disoproxil fumarate plus emtricitabine versus placebo and demonstrated a positive eff ect on incidence. 111 We identifi ed fi ve RCTs of HIV vaccines in two reviews. One trial (RV144), a large trial conducted in 2009 in Thailand with the ALVAC-HIV vaccine and AIDSVAX B/E boosters, demonstrated moderate effi cacy. 112 In a modifi ed intention-to-treat analysis, vaccine effi cacy was 31·2% (95% CI 1·1-52·1). Other vaccines trialled have not protected against HIV infection or reduced viral load, including the MRKAd5 HIV-1 gag/pol/nef subtype B vaccine used in the Step and Phambili studies, which was discontinued at interim analysis because it showed no protective eff ect. 113, 114 Demand-focused interventions: 40 reviews (108 primary studies [ Mass condom distribution and associated policies (20) ; needle and syringe programmes and associated policies (6); health system policies: integration of family planning and HIV (6); STI control (3) 
Discussion
We found evidence from several randomised trials in support of the effi cacy of direct mechanisms to prevent HIV. Evidence also suggests that supply-side interventions that increase access to these effi cacious technologies can be eff ective, and that there is a need for continued research on interventions to increase demand for and adherence to direct mechanisms to prevent HIV.
As the cascade highlights, demand, supply, and use of interventions are all crucial domains to increases in uptake of and adherence to direct HIV prevention mechanisms. The interventions and com bination of interventions required to translate the effi cacy of direct mechanisms into population-level impact will require monitoring for these domains to understand gaps and support intervention development. HIV prevention technologies such as male and female condoms or clean injecting equipment have existed for several years. In recent years, evidence for the effi cacy of other direct mechanisms, including medical male circumcision and oral PrEP, has emerged. Much is left to learn about how these mechanisms increase coverage and support adherence to achieve population-level impacts. Our review identifi ed a range of potential interventions addressing these elements of the cascade. Supply-side interventions, such as mass condom distribution and needle and syringe exchange initiatives, have shown impact on use of these methods. However, relatively few studies have explored the eff ect of these interventions on HIV outcomes, and where these were studied, randomised trials have rarely been used.
Findings from demand-side interventions such as information, education, and communication and peerbased interventions on HIV outcomes have been disappointing, with these interventions rarely reducing HIV incidence or prevalence. Few trials and studies identifi ed in the reviews evaluated interventions to increase demand for medical male circumcision or adherence to PrEP, although evidence for this domain is emerging. 115, 116 There remains a need for additional research to understand why, despite supply, there is low uptake of these strategies and for evaluations of novel interventions to increase this uptake and adherence. With evidence arising on how to increase demand for medical male circumcision, systematic reviews of such strategies are warranted. As new direct mechanisms, including microbicides and vaccines, emerge, lessons learned from existing interventions could improve access. 116 The evidence for the eff ectiveness of supply-side interventions is a timely reminder of the gains that can be made in HIV prevention by making prevention products accessible and available to populations in need. In circumstances where social barriers threaten eff orts to reduce HIV incidence, these interventions can be eff ective at increasing access to HIV prevention methods and possibly reducing incidence. Policy changes are sometimes necessary to create the platforms to ensure biomedical and behavioural interventions reach and can be used by those who need them at scale. Overall, our review draws similar conclusions to Mavadzenge and colleagues: 5 there is some evidence that in-school inter ventions can have an impact on some HIV outcomes, and there is proven effi cacy of several biomedical HIV prevention tools.
Our mapping of the literature highlights that distinction between the structural and the behavioural has not clearly distinguished interventions, and that classifying interventions this way might have created some confusion. For example, Stepping Stones was identifi ed in reviews of interventions targeted at young people and women and in a review to explore the eff ect of this intervention on individual biological outcomes through to structural level changes in gender norms. 100 Similarly, an intervention of social marketing to youth for condom use was included in reviews identifi ed through the behavioural search and the structural search. 103 These examples highlight that defi ning the level at which an intervention operates might be less useful than would categorising it by the objective of the intervention (eg, to increase demand for HIV prevention or support adherence).
Our review also shows the many gaps that still exist in the literature on the eff ectiveness of interventions for HIV prevention, particularly when it comes to demandside, supply-side, and adherence interventions. Although we identifi ed a large number of studies across these typologies, most were observational in design and often relied on self-reported behavioural outcomes. This might be interpreted as meaning that these studies contribute less to the evidence base for eff ectiveness than do those using randomised trial designs. However, observational studies are necessary and important when randomisation is either not feasible or even unethical, providing strong evidence that an intervention likely had an eff ect if the design is robust. As stated, our goal here is to describe the current state of HIV prevention research and to highlight key research gaps. As such, it is necessary to describe the evidence from these studies, alongside that from studies with more robust study designs to accurately map the state of the evidence.
Our mapping method has several limitations. First, our search strategy might have missed reviews of prevention technologies. However, in light of the large overlap found between the primary studies included in the reviews, we consider it unlikely that this would have led to us excluding a large number of relevant primary studies or have aff ected our overall conclusions. Second, because we carried out a review of reviews, we only assessed studies that were themselves included in a systematic review (no extra studies of biomedical HIV prevention interventions were included when we opened the search to primary papers). Such an approach will inevitably miss recently published studies. For example, the FACTS 001 trial, a phase 3, multicentre RCT in South Africa that evaluated the safety and eff ectiveness of pericoital tenofovir 1% gel, announced trial results in early 2015 and was therefore not included in any systematic reviews we identifi ed. The study found no evidence of an eff ect on HIV incidence. 117 Results of two trials showing effi cacy of oral PrEP in MSM were also published after our search. 118, 119 The one review we identifi ed that described cash transfer interventions included 16 studies, but at the time of publication, only three studies had reported relevant data on HIV-related outcomes. Subsequently, fi ndings from at least one study, the HPTN 068 trial, have been released. 120 Third, we identifi ed a large number of primary studies of complex interventions that had components aimed at increasing demand through information, education, and communication and peer interventions. We aimed to map interventions to the HIV prevention framework by the main intervention component. However, classifi cation was subjective and reviewers might classify inter ventions diff erently or might have opted to categorise interventions into multiple categories. The implications of this are that we might under-report available evidence in a certain category. We opted to classify studies into only one category to avoid overstating the evidence available on HIV prevention interventions. Additionally, two reviewers discussed classifi cation in detail and consulted a third if there was strong disagreement and so it is unlikely that any mis classifi cation would change our fi ndings substantially.
Fourth, where possible, we discussed the available evidence for biological HIV outcomes. However, selfreported behavioural outcomes were often the only measure of intervention eff ect presented in studies, particularly those describing demand-side, adherence, and supply-side interventions. Such outcomes have insuffi cient ability to show actual changes in behaviour; however, only including studies that reported biological HIV outcomes would have vastly reduced the number of primary studies assessed. The inclusion of studies assessing condom use as an outcome allows us to describe evidence from key interventions that align with the prevention cascade. By including these studies, we highlight evidence showing that interventions do infl uence proximate measures of demand, supply, and adherence.
Finally, our objective was to do a systematic review of systematic reviews. Our objective was not to assess the methodological rigour of the primary studies identifi ed by these reviews. Our decision to categorise primary studies, rather than the reviews themselves, into the specifi c cascade domains was led by the large overlap across primary studies included in the reviews. As such, our review provides an overview of the rigour and strength of the evidence; however, it does not provide nuanced detail of the quality of the primary studies. 5 Given the minimal data extraction that we did at the level of the primary study, we cannot comment on hetero geneity across populations included in the studies. We appreciate that it is important to understand whether populations in studies with robust study designs and showing consistent eff ectiveness are similar or diff erent to those in studies using mostly observational study designs, and demonstrating inconsistent or no eff ective ness. Understanding the potential relationship between evidence quality and the populations studied is an important next step. Again, our objective was not to critically appraise primary studies or specifi c interventions but to map where along the prevention cascade evidence of interventions is available, the number and type of studies, and whether these studies generally supported the intervention or not. A primary goal was to highlight areas in which more research is needed.
The current evidence base on HIV prevention shows that we have methods that work at the individual level, and that the goal of ensuring population-level eff ect is achievable through the use of interventions that support demand for HIV prevention, supply of HIV prevention technologies, and adherence to the direct mechanisms that prevent HIV. The use of an HIV prevention cascade that includes these domains provides a framework to understand why a proven direct mechanism is failing to have a population-level impact and support the development and implementation of interventions to target these domains. Systematic reviews that explore the current evidence in the four categories identifi ed in this paper should be done to understand fully what works, for whom, and under which circumstances. This is an essential next step for the evidence mapping we have initiated here. Future research that builds on the current evidence base and shows approaches to gaining impact for HIV prevention methods is necessary to ensure intervention eff ectiveness.
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